Trial intelligence / Profile preview

Sevelamer Carbonate vs Calcium Acetate in CKD Stages 3-4

NCT01277497Phase 4Terminated

Sponsor
Albany College of Pharmacy and Health Sciences
Start
Jan 2011
Primary completion
Jan 2016
Modality
Polymer-based Nanoparticles, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of sevelamer carbonate in chronic kidney disease (CKD), sponsored by Albany College of Pharmacy and Health Sciences. Started Jan 2011; status: terminated.

02

Drugs

sevelamer carbonate
03

Conditions

chronic kidney disease (CKD)

Beyond the preview

Go deeper on NCT01277497.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01277497.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call